TL;DR: College athletes were surveyed about their knowledge and practice of early cancer detection techniques and males were almost completely unaware of their risk for testicular cancer.
Abstract: College athletes were surveyed about their knowledge and practice of early cancer detection techniques. Males were almost completely unaware of their risk for testicular cancer (87%). Only 9.6% had been taught testicular self-examination and only half of these by their physician. Six percent actually examined themselves regularly. In comparison, more than 60% of women had been taught breast self-examination (75% by a physician) and about one third were doing regular examinations. More than 90% of the young men and women had been seen by physicians for a physical examination within the past 3 years. Physicians need to begin educating males about testicular cancer and its early detection.
TL;DR: The table shows the uptake of prenatal diagnosis, with a total of 105 patients (81%) electing to be tested and 82 patients electing amniocentesis all obtained a result after the first tap and none subsequently aborted.
Abstract: gestation and were therefore potential candidates for chorionic villus sampling. Eighteen of these patients had a non-viable pregnancy at booking and seven aborted spontaneously before testing, giving a loss in this group of 26%. Among the 59 patients booking after more than 11 weeks' gestation there were only three losses before testing leaving a total of 129 patients with continuing pregnancies, to whom tests were offered. The table shows the uptake of prenatal diagnosis, with a total of 105 patients (81%) electing to be tested. Chorionic villus sampling was successful in achieving a diagnosis in 21 of 23 patients tested, but one patient aborted a normal fetus four weeks after an uncomplicated procedure. Two chorionic villus sampling procedures failed to obtain an adequate sample; one of the patients aborted five days afterwards with ruptured membranes and the other delivered normally after an uncomplicated amniocentesis. The 82 patients electing amniocentesis all obtained a result after the first tap and none subsequently aborted.
TL;DR: Testicular microlithiasis is common and while microcalcifications do exist in roughly 50% of germ cell tumors the majority of men with testicular micro lithiasis will not develop testicular cancer.
Abstract: Purpose of reviewAnecdotal reports of men developing testicular cancer after previous identification of microcalcifications on ultrasound generated significant concern in the literature about the relationship of testicular microlithiasis and testis cancer. Until 2001 little prospective data were ava
TL;DR: A large number of clinical evaluations based on the TSE for benign disease can be made compared to the cost of one missed advanced‐stage tumor, and an average of 2.4 to 1 cost benefit ratio was demonstrated for early detected testicular cancer versusAdvanced‐stage disease.
Abstract: The United States Preventive Services Task Force (USPSTF) has recommended against testicular self-examinations (TSE) or clinical examination for testicular cancer screening. However, in this recommendation there was no consideration of the significant fiscal cost of treating advanced disease versus evaluation of benign disease. In this study, a cost-utility validation for TSE was performed. The cost of treatment for an advanced-stage testicular tumor (both seminomatous and nonseminomatous) was compared to the cost of six other scenarios involving the clinical assessment of a testicular mass felt during self-examination (four benign and two early-stage malignant). Medicare reimbursements were used as an estimate for a national cost standard. The total treatment cost for an advanced-stage seminoma ($48,877) or nonseminoma ($51,592) equaled the cost of 313–330 benign office visits ($156); 180–190 office visits with scrotal ultrasound ($272); 79–83 office visits with serial scrotal ultrasounds and labs ($621); 6–7 office visits resulting in radical inguinal orchiectomy for benign pathology ($7,686) or 2–3 office visits resulting in treatment and surveillance of an early-stage testicular cancer ($17,283: seminoma, $26,190: nonseminoma). A large number of clinical evaluations based on the TSE for benign disease can be made compared to the cost of one missed advanced-stage tumor. An average of 2.4 to 1 cost benefit ratio was demonstrated for early detected testicular cancer versus advanced-stage disease.
TL;DR: Intention, outcome expectancies and self-efficacy were the best predictors of testicular self-examination performance and provided some support for the Health Action Process Approach.
Abstract: One-hundred-and-one Australian university students aged 18-25 years, with a mean age of 22.9 years (SD=1.62) completed a survey assessing testicular self-examination, and knowledge of testicular cancer. A statistically significant difference was found in knowledge scores between performers and non-performers. The factors influencing performance of testicular self-examination were examined using Schwarzer's (1992) Health Action Process Approach as the theoretical framework. Results showed that the majority of men were uninformed or misinformed about testicular cancer and testicular self-examination. Eighty-three per cent of respondents did not perform testicular self-examination once per month as recommended. Intention, outcome expectancies and self-efficacy were the best predictors of testicular self-examination performance. Findings provided some support for the Health Action Process Approach.